Foghorn Therapeutics (FHTX) Competitor Comparison
We are evaluating the key criteria listed to compare Foghorn Therapeutics (FHTX) against its competitors in the Biotechnology industry.
Market Capitalization
201 / 368Gross Profits
230 / 278Total Revenue
141 / 300EBITDA
217 / 337Free Cashflow
234 / 352Quick Ratio
186 / 357Earnings per Share
203 / 359Dividend yield
0 / 6Total Cash
124 / 358Performance 3 years
139 / 368Performance 5 years
180 / 368Performance 10 years
152 / 368Linearity 3 years
66 / 368Linearity 5 years
96 / 368Linearity 10 years
93 / 368Total Rank
128 / 368Dividend Rank
131 / 368Valuation Rank
52 / 368Piotroski Rank
74 / 368Muliplier Rank
346 / 368Gross Profits - FHTX ranking 230 / 278
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.